Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cannula | 4 | 2021 | 750 | 1.61 | Why? |
| Oxygen Inhalation Therapy | 6 | 2021 | 3629 | 1.31 | Why? |
| Positive-Pressure Respiration | 4 | 2017 | 1160 | 0.94 | Why? |
| Inhalation | 1 | 2021 | 86 | 0.85 | Why? |
| Hyperoxia | 1 | 2019 | 51 | 0.75 | Why? |
| Subcutaneous Fat | 1 | 2018 | 94 | 0.70 | Why? |
| Intubation, Intratracheal | 3 | 2017 | 3962 | 0.66 | Why? |
| Nomograms | 2 | 2020 | 790 | 0.66 | Why? |
| Intra-Abdominal Fat | 1 | 2018 | 227 | 0.62 | Why? |
| Noninvasive Ventilation | 3 | 2017 | 2329 | 0.61 | Why? |
| Conscious Sedation | 1 | 2017 | 222 | 0.59 | Why? |
| Analgesia | 1 | 2017 | 211 | 0.56 | Why? |
| Acute Lung Injury | 3 | 2018 | 904 | 0.55 | Why? |
| Aspartate Aminotransferases | 1 | 2021 | 1394 | 0.53 | Why? |
| Analgesics | 1 | 2017 | 451 | 0.50 | Why? |
| Patient Outcome Assessment | 1 | 2017 | 707 | 0.48 | Why? |
| Indoles | 1 | 2020 | 1243 | 0.46 | Why? |
| Out-of-Hospital Cardiac Arrest | 1 | 2019 | 1047 | 0.37 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.36 | Why? |
| Intensive Care Units | 8 | 2021 | 29594 | 0.28 | Why? |
| Neutrophils | 1 | 2021 | 5476 | 0.27 | Why? |
| Hospital Mortality | 5 | 2019 | 22087 | 0.27 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.26 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.26 | Why? |
| Prognosis | 5 | 2020 | 32490 | 0.24 | Why? |
| Airway Extubation | 2 | 2017 | 403 | 0.24 | Why? |
| Maximal Respiratory Pressures | 1 | 2021 | 16 | 0.23 | Why? |
| Acute Kidney Injury | 1 | 2021 | 5762 | 0.21 | Why? |
| Comparative Effectiveness Research | 1 | 2021 | 178 | 0.21 | Why? |
| Logistic Models | 3 | 2020 | 9089 | 0.20 | Why? |
| Bacillus Phages | 1 | 2018 | 3 | 0.20 | Why? |
| Lysogeny | 1 | 2018 | 5 | 0.20 | Why? |
| Bacteriolysis | 1 | 2018 | 9 | 0.20 | Why? |
| Length of Stay | 4 | 2017 | 11042 | 0.19 | Why? |
| Materials Testing | 1 | 2021 | 380 | 0.18 | Why? |
| China | 9 | 2021 | 50654 | 0.18 | Why? |
| Tidal Volume | 1 | 2021 | 565 | 0.18 | Why? |
| ROC Curve | 2 | 2020 | 6024 | 0.18 | Why? |
| Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 40 | 0.17 | Why? |
| Analysis of Variance | 1 | 2021 | 950 | 0.17 | Why? |
| Odds Ratio | 2 | 2019 | 5861 | 0.16 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.16 | Why? |
| Postoperative Period | 1 | 2019 | 651 | 0.16 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.16 | Why? |
| Respiration, Artificial | 3 | 2019 | 22116 | 0.16 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.15 | Why? |
| Critical Illness | 1 | 2019 | 17281 | 0.14 | Why? |
| Adult | 13 | 2021 | 244371 | 0.14 | Why? |
| Troponin T | 1 | 2020 | 771 | 0.14 | Why? |
| Observational Studies as Topic | 2 | 2020 | 1887 | 0.14 | Why? |
| Brain Injuries, Traumatic | 1 | 2019 | 381 | 0.13 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.13 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.12 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.12 | Why? |
| Humans | 24 | 2021 | 930598 | 0.12 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.12 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.12 | Why? |
| Early Diagnosis | 1 | 2021 | 2443 | 0.12 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.11 | Why? |
| Educational Status | 1 | 2018 | 1451 | 0.11 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.11 | Why? |
| Respiratory Therapy | 1 | 2018 | 918 | 0.11 | Why? |
| Leukocyte Count | 1 | 2021 | 3178 | 0.11 | Why? |
| Male | 13 | 2021 | 367725 | 0.11 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.11 | Why? |
| Nursing Staff | 1 | 2018 | 542 | 0.11 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.11 | Why? |
| Overweight | 1 | 2017 | 916 | 0.10 | Why? |
| Female | 12 | 2021 | 380317 | 0.10 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.10 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.10 | Why? |
| Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 234 | 0.10 | Why? |
| Forkhead Transcription Factors | 1 | 2010 | 231 | 0.10 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.10 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.09 | Why? |
| Professional Role | 1 | 2018 | 1280 | 0.09 | Why? |
| Cross Infection | 2 | 2020 | 8675 | 0.09 | Why? |
| Heart Arrest | 1 | 2019 | 1239 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.09 | Why? |
| Aged | 7 | 2021 | 215776 | 0.08 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.08 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.08 | Why? |
| Communicable Diseases, Emerging | 1 | 2020 | 2523 | 0.08 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2019 | 1931 | 0.07 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.07 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2019 | 1876 | 0.07 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2020 | 10649 | 0.07 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2019 | 5002 | 0.06 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.06 | Why? |
| Emergency Medical Services | 1 | 2019 | 3557 | 0.06 | Why? |
| Mortality | 1 | 2019 | 7132 | 0.06 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.05 | Why? |
| Viral Proteins | 1 | 2018 | 7370 | 0.05 | Why? |
| Dexamethasone | 1 | 2010 | 2055 | 0.05 | Why? |
| Bacillus subtilis | 1 | 2018 | 34 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.04 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Endotoxins | 1 | 2017 | 80 | 0.04 | Why? |
| I-kappa B Kinase | 1 | 2017 | 98 | 0.04 | Why? |
| Gene Expression Regulation, Developmental | 1 | 2017 | 159 | 0.04 | Why? |
| Licensure | 1 | 2018 | 144 | 0.04 | Why? |
| Specific Pathogen-Free Organisms | 1 | 2017 | 358 | 0.04 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Certification | 1 | 2018 | 261 | 0.04 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.04 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.03 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.03 | Why? |
| Inservice Training | 1 | 2018 | 477 | 0.03 | Why? |
| Virus Shedding | 2 | 2021 | 5834 | 0.03 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2020 | 1262 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Cardiovascular Agents | 1 | 2020 | 663 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2020 | 1289 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Taiwan | 1 | 2020 | 2556 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2018 | 2219 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2018 | 1647 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Asthma | 1 | 2010 | 4383 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2018 | 2689 | 0.03 | Why? |
| Bronchoscopy | 1 | 2018 | 991 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.03 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.02 | Why? |
| Peptide Fragments | 1 | 2020 | 2075 | 0.02 | Why? |
| Alveolar Epithelial Cells | 1 | 2017 | 1445 | 0.02 | Why? |
| Random Allocation | 1 | 2010 | 773 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2018 | 6049 | 0.02 | Why? |
| Peptides | 1 | 2018 | 2513 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Binding Sites | 1 | 2018 | 6201 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Mice | 2 | 2017 | 21357 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.01 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Mice, Inbred BALB C | 1 | 2010 | 5814 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Animals | 2 | 2017 | 78931 | 0.01 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Lung | 1 | 2017 | 31049 | 0.01 | Why? |
Liang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(136)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_